The Efficacy of Oral Antiseptics Against COVID-19

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

December 7, 2021

Conditions
COVID-19
Interventions
DRUG

Hypochlorous Acid 0.02% Soln,Top (Crystaline) (HClO)

SARS-CoV-2 sample was obtained from COVID-19 patients by rinsing the mouth and throat with 5 ml of isotonic saline before and 30 minutes after rinsing. In the hypochlorous acid group, 20 ml of HClO was asked to be rinsed in the mouth and throat for 30 seconds in 25 participants. In the povidone-iodine group, 20 ml of PVP-I was asked to be rinsed in the mouth and throat for 30 seconds in 25 participants. In the saline group, 20 ml of saline was asked to be rinsed in the mouth and throat for 30 seconds in 25 participants.

Trial Locations (1)

25240

Atatürk University Faculty of Dentistry, Erzurum

All Listed Sponsors
lead

Ataturk University

OTHER

NCT05214196 - The Efficacy of Oral Antiseptics Against COVID-19 | Biotech Hunter | Biotech Hunter